Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Dec 10, 2009
Watch Kimberly L. Blackwell, M.D., associate professor of medicine and director of the Clinical Trials Program in Breast Cancer at Duke University Medical Center talk about "Updated Survival Analysis of a Randomized Study of Lapatinib Alone or in Combination with Trastuzumab in Women with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab Therapy."